Amneal Pharmaceuticals
AMRX
C$10.53
Share price
-2.64%
Change (1 day)
9.45%
Change (1 year)
Categories
P/S ratio for Amneal Pharmaceuticals (AMRX)
P/S ratio as of June 2025 (TTM): 1.29
According to Amneal Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -61.3. At the end of 2025 the company had a P/S ratio of 1.36.
P/S ratio history for Amneal Pharmaceuticals from 2018 to 2025
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2025 | 1.36 | 5.33% |
| 2024 | 1.29 | 66.33% |
| 2023 | 0.7774 | 184.66% |
| 2022 | 0.2731 | -20.09% |
| 2021 | 0.3417 | 0.93% |
| 2020 | 0.3386 | -61.81% |
| 2019 | 0.8867 | -63.51% |
| 2018 | 2.43 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | 92.5 | 7,086.42% | 🇺🇸 USA |
 OPKO Health
OPK | 1.55 | 20.21% | 🇺🇸 USA |